Session » Abstracts: Pediatric Rheumatology – Clinical I (1668–1673)
- 1:00PM-1:15PM
-
Abstract Number: 1668
A clinically validated assay for rapid determination of type I and type II interferon activity in pediatric inflammatory diseases
- 1:15PM-1:30PM
-
Abstract Number: 1669
Development and Validation of Minimal Disease Activity and Disease Flare for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
- 1:30PM-1:45PM
-
Abstract Number: 1670
Large Retrospective Cohort Study Of Chronic Recurrent Multifocal Osteomyelitis: Disease Presentation, Clinical, And Laboratory Features
- 1:45PM-2:00PM
-
Abstract Number: 1671
Emapalumab Treatment for Patients with Differing Presentations of Macrophage Activation Syndrome (MAS) Secondary to Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials
- 2:00PM-2:15PM
-
Abstract Number: 1672
Classification criteria, disease phenotypes and long-term outcomes of childhood Sjögren’s Disease into adulthood
- 2:15PM-2:30PM
-
Abstract Number: 1673
Is Transient Synovitis of the Hip preclinical Juvenile SpA ? A follow-up study